“Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma”, JOC, vol. 24, no. 8s, pp. 553–562, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.553-562.